CMFChemotherapyIntraductalPapillomaPathologicResponsePalpationOligometastasesCapecitabineMultimodalityTherapySERMDefinitiveSurgeryLapatinibMethotrexatePI3KinaseInhibitorsAntibodyTherapyRADChemotherapyAbsoluteRiskFISHCalcificationsMastectomyLymphoscintigraphyCheckpointInhibitorCytostaticCytotoxicHerceptinAngiogenesisMRIBevacizumabTamoxifenRelapseDoxorubicinTyrosine-KinaseInhibitorAdvocacyDown-StagingAyurvedaMastodyniaIn-situCarcinomaACChemotherapyApoptosisProgestinPhyllodesTumorWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AntiemeticsBreastTomosynthesisBilateralProphylacticMastectomyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearFibroadenomaCachexiaLumpectomymTORInhibitorsRadiotherapyAdenocarcinomaBiopsyStagingBRCAGeneRaloxifenePaclitaxelFamilyHistoryECOGScoreTriple +/-BreastCancerLumpMorpheaMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltGailModelAromataseInhibitorsMegestrolAcetateCDK4/6Inhibitors1 in 8womenLCISBI-RADSEstrogen/EstradiolDimplingAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCAMPhysicalactivity mayreduce therisk of breastcancersImmunotherapyAnastrozoleGeneticPredispositionFlowCytometrySelf-examinationNeoadjuvantTherapyHormoneReceptorStatusPrecisionMedicineGeneticCounselingBreastCancerGermlineMutationKappaEpsilonWomen ages40+ shouldhave a clinicalbreast examat least yearlyGuaranteedRenewableInsuranceAlopeciaCyclophosphamideBOCAHormoneReplacementTherapyKi-67RateER+/-AdjuvantTherapyDocetaxelBrachytherapyMetastasisHER-2EGFRMultifocalTumorsGeneMutationLymphNodeStatusDoseDenseTherapyTumorGradeCystPalbociclibOvarianSuppressionPagetDisease5-FluorouracilBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55Co-survivorPARPInhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenChemopreventionFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.CMFChemotherapyIntraductalPapillomaPathologicResponsePalpationOligometastasesCapecitabineMultimodalityTherapySERMDefinitiveSurgeryLapatinibMethotrexatePI3KinaseInhibitorsAntibodyTherapyRADChemotherapyAbsoluteRiskFISHCalcificationsMastectomyLymphoscintigraphyCheckpointInhibitorCytostaticCytotoxicHerceptinAngiogenesisMRIBevacizumabTamoxifenRelapseDoxorubicinTyrosine-KinaseInhibitorAdvocacyDown-StagingAyurvedaMastodyniaIn-situCarcinomaACChemotherapyApoptosisProgestinPhyllodesTumorWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AntiemeticsBreastTomosynthesisBilateralProphylacticMastectomyEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearFibroadenomaCachexiaLumpectomymTORInhibitorsRadiotherapyAdenocarcinomaBiopsyStagingBRCAGeneRaloxifenePaclitaxelFamilyHistoryECOGScoreTriple +/-BreastCancerLumpMorpheaMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltGailModelAromataseInhibitorsMegestrolAcetateCDK4/6Inhibitors1 in 8womenLCISBI-RADSEstrogen/EstradiolDimplingAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerCAMPhysicalactivity mayreduce therisk of breastcancersImmunotherapyAnastrozoleGeneticPredispositionFlowCytometrySelf-examinationNeoadjuvantTherapyHormoneReceptorStatusPrecisionMedicineGeneticCounselingBreastCancerGermlineMutationKappaEpsilonWomen ages40+ shouldhave a clinicalbreast examat least yearlyGuaranteedRenewableInsuranceAlopeciaCyclophosphamideBOCAHormoneReplacementTherapyKi-67RateER+/-AdjuvantTherapyDocetaxelBrachytherapyMetastasisHER-2EGFRMultifocalTumorsGeneMutationLymphNodeStatusDoseDenseTherapyTumorGradeCystPalbociclibOvarianSuppressionPagetDisease5-FluorouracilBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55Co-survivorPARPInhibitorsAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenChemopreventionFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
  1. CMF Chemotherapy
  2. Intraductal Papilloma
  3. Pathologic Response
  4. Palpation
  5. Oligometastases
  6. Capecitabine
  7. Multimodality Therapy
  8. SERM
  9. Definitive Surgery
  10. Lapatinib
  11. Methotrexate
  12. PI3 Kinase Inhibitors
  13. Antibody Therapy
  14. RAD
  15. Chemotherapy
  16. Absolute Risk
  17. FISH
  18. Calcifications
  19. Mastectomy
  20. Lymphoscintigraphy
  21. Checkpoint Inhibitor
  22. Cytostatic
  23. Cytotoxic
  24. Herceptin
  25. Angiogenesis
  26. MRI
  27. Bevacizumab
  28. Tamoxifen
  29. Relapse
  30. Doxorubicin
  31. Tyrosine-Kinase Inhibitor
  32. Advocacy
  33. Down-Staging
  34. Ayurveda
  35. Mastodynia
  36. In-situ Carcinoma
  37. AC Chemotherapy
  38. Apoptosis
  39. Progestin
  40. Phyllodes Tumor
  41. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  42. Antiemetics
  43. Breast Tomosynthesis
  44. Bilateral Prophylactic Mastectomy
  45. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  46. Fibroadenoma
  47. Cachexia
  48. Lumpectomy
  49. mTOR Inhibitors
  50. Radiotherapy
  51. Adenocarcinoma
  52. Biopsy
  53. Staging
  54. BRCA Gene
  55. Raloxifene
  56. Paclitaxel
  57. Family History
  58. ECOG Score
  59. Triple +/- Breast Cancer
  60. Lump
  61. Morphea
  62. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  63. Gail Model
  64. Aromatase Inhibitors
  65. Megestrol Acetate
  66. CDK4/6 Inhibitors
  67. 1 in 8 women
  68. LCIS
  69. BI-RADS
  70. Estrogen/Estradiol
  71. Dimpling
  72. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  73. CAM
  74. Physical activity may reduce the risk of breast cancers
  75. Immunotherapy
  76. Anastrozole
  77. Genetic Predisposition
  78. Flow Cytometry
  79. Self-examination
  80. Neoadjuvant Therapy
  81. Hormone Receptor Status
  82. Precision Medicine
  83. Genetic Counseling
  84. Breast Cancer
  85. Germline Mutation
  86. Kappa Epsilon
  87. Women ages 40+ should have a clinical breast exam at least yearly
  88. Guaranteed Renewable Insurance
  89. Alopecia
  90. Cyclophosphamide
  91. BOCA
  92. Hormone Replacement Therapy
  93. Ki-67 Rate
  94. ER +/-
  95. Adjuvant Therapy
  96. Docetaxel
  97. Brachytherapy
  98. Metastasis
  99. HER-2
  100. EGFR
  101. Multifocal Tumors
  102. Gene Mutation
  103. Lymph Node Status
  104. Dose Dense Therapy
  105. Tumor Grade
  106. Cyst
  107. Palbociclib
  108. Ovarian Suppression
  109. Paget Disease
  110. 5-Fluorouracil
  111. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  112. Co-survivor
  113. PARP Inhibitors
  114. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  115. Chemoprevention
  116. For every 1,000 screening mammograms performed, about five breast cancers are detected.